Concord Biotech Limited is a renowned biopharma company focused on research and development (R&D). With expertise in fermentation and semi-synthetic processes, Concord manufactures Active Pharmaceutical Ingredients (API) and finished formulations. Over the years, the brand has evolved from a single-product company to become a leading provider of solutions across various therapeutic segments.

Concord is globally recognized for its high-quality products, serving customers in more than 70 countries, including the USA, Europe, Japan, and Latin America. The company has state-of-the-art manufacturing facilities, including two API manufacturing units and one finished formulation unit, all located near Ahmedabad, Gujarat, India. These facilities undergo rigorous inspections from regulatory authorities such as the USFDA, EUGMP, WHO, PMDA, and MFDS.

Additionally, Concord has dedicated R&D units for APIs and formulations, approved by DSIR, India. Driven by its vision and mission, Concord aims to enrich lives through biotechnology by continuously building on its expertise. The brand offers a wide range of contract research and manufacturing services for global markets, including strain improvement, process development, formulation development, and analytical capabilities.

With a strong global presence and a commitment to excellence, Concord Biotech Limited is a trusted partner in the pharmaceutical industry